Clinical Trials

Study name: Phase II Open Labeled Trial of Disulfiram with Copper in Metastatic Breast Cancer
Study type: phase II open labeled clinical trial
Population: metastatic breast cancer patients
Protocol number: 2016-1-DSF-MBC
Trial number: 2016-001386-81 (EduraCT)
Status: recruiting
Study name: Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery
Study type: prospective, randomized
Population: patients undergoing collorectal cancer surgery
Trial number: NCT02314871
Status: recruiting
Study name: A multi-center retrospective study for developing and validating a microRNA based assay for the classification of indeterminate thyroid FNA samples
Study type: retrospective biomarker identification and validation study
Population: patients with thyroid diseases, preferrably thyroid cancer
Protocol number: RG-Thyroid-DD-21-28
Status: terminated
Study name: Placebo controlled phase II clinical study of antioxidant lycopene on oxidative stress in cystic fibrosis and male infertility patients.
Study type: placebo controlled phase II study
Population: cystic fibrosis patients (pediatric and adults), healthy cystic fibrosis heterozygotes, healthy volunteers and infertile men.
Protocol number: 1A8621
Status: terminated
Study name: A randomized, single-dose, two-way cross-over study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing atorvastatin.
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 176/022/04-iqa
Status: terminated
Study name: Genomic profiling of locally advanced rectal cancers in prediction of chemotherapy response.
Study type: prospective biomarker identification and validation study
Population: rectal cancer patietns
Protocol number: NR9076
Status: terminated
Study name: Molecular predictive biomarkers of EGFR inhibitors combined with radiotherapy in head and neck cancer patients.
Study type: prospective biomarker identification and validation study
Population: head and neck cancer patients
Protocol number: NS10108
Status: terminated
Study name: Detection and clinical significance of minimal residual disease/circulating tumor cells in patients undergoing surgery for colorectal cancer.
Study type: prospective biomarker validation study
Population: stage I-IV colorectal cancer patients
Protocol number: NR7804
Status: terminated
Study name: Clinical significance of minimal residual disease/circulating tumor cells in pancreatic adenocarcinoma patients.
Study type: prospective biomarker identification and validation study
Population: pancreatic adenocarcinoma patients
Protocol number: NS9937
Status: terminated
Study name: Molecular basis of glucocorticoid response in children acute lymphoblastic leukemia.
Study type: prospective biomarker identification and validation study
Population: acute lymphoblastic leukemia children
Protocol number: NS9939
Status: terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing citalopram.
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 78/013/02-iqa
Status: terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing simvastatin.
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 77/014/02-iqa
Status: terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing pioglitazone.
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 78/015/02-iqa
Status: terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing glibenclamide (glyburide).
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 77/012/02-iqa
Status: terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing azithromycine.
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 77/011/02-iqa
Status: terminated
Study name: A ramdomized, single-dose, two-way crossover study in healthy volunteers to determine the bioequivalence of two oral drug formulations containing itraconazole.
Study type: bioequivalence study
Population: healthy volunteers
Protocol number: 78/016/02-iqa
Status: terminated
Study name: PROTAXEL PHASE I STUDY. Single - center open study of the toxicity, safety, tolerability and kinetics of individually ascending doses of Protaxel in patients with refractory/recurrent ovarian or prostate cancer.
Study type: phase I clinical trial
Population: paclitaxel refractory/recurrent advanced ovarian or prostate cancer patients
Protocol number: PTX-I-01 2001
Status: terminated
Study name: Clinical Efficacy and Safety of a Cosmetic Topical Agent, Fluridil, in Male Androgenic Alopecia
Study type: phase II clinical trial
Population: males with androgenic alopecia
Protocol number: FLUR-2000
Status: terminated